South Asian Declaration-Consensus Guidelines for COVID-19 Vaccination in Cancer Patients.

Autor: Thirumalairaj R; Department of Medical Oncology, Apollo Cancer Center, Teynampet, Chennai, India., Parikh PM; Department of Oncology, Integrated Academic Society of Clinical Oncology, Mumbai Oncocare Centers, Mumbai, Maharashtra, India., Agarwal A; Department of Medical Oncology, BLK Superspecilaity Hospital, Delhi, India., Singh R; Department of Molecular Oncology Society, Narayana Health, Delhi, India., Krishnamurthy A; Department of Surgical Oncology, Cancer Institute (WIA), Chennai, India., Desai SS; Department of Surgical Oncology, Mahatma Gandhi Cancer Hospital, Miraj, Maharashtra, India., Maheshwari A; Divison of Gynecologic Oncology, Department of Surgical Oncology, Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, Maharashtra, India., Mehta P; Department of Medical Oncology/Hematoncology/BMT, Asian Institute of Medical Sciences, Faridabad, India., Ghafur A; Department of Infectious Diseases, Apollo Cancer Institute, Chennai, India., Somashekhar SP; Department of Surgical Oncology, MHEPL, Manipal Comprehensive Cancer Center, Manipal Hospital, Bengaluru, India., Iqbal A; Oncology and Radiotherapy Department, Teaching Hospital, Batticaloa, Sri Lanka., Savant DN; Department of Surgical Oncology, Asian Cancer Institute, Mumbai, Maharashtra, India., Hussain SMA; Department of Radiotherapy, Square Oncology and Radiotherapy Centre, Dhaka, Bangladesh., Bhatt A; Department of Medical Oncology, Avinash Cancer Clinic, Pune, India., Wangdi T; Oncology Department, JDWNR Hospital and KGUMS, Thimphu, Bhutan., Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India., Ranade AA; Department of Medical Oncology, Avinash Cancer Clinic, Pune, India., Babu KG; Department of Medical and Pediatric Oncology, St. Johns Medical College and Hospital, HCG Hospitals, Bangalore, India., Bapna A; Department of Medical Oncology, BMCHRC, Jaipur, Rajasthan, India., Biswas G; Department of Medical Oncology, Sparsh Hospital and Sum Hospital, Bhubaneswar, Odisha, India., Malhotra H; Department of Medical Oncology, Sri Ram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, Rajasthan, India., Krishna MV; Department of Medical Oncology and Hematology, Institute of Oncology, AIG Hospitals, Gachibowli, Hyderabad, India., Baral RP; Department of Medical Oncology, Norvic International Hospital and Om Hospital and Research Center, Kathmandu, Nepal., Vashishtha R; Department of Radiation Oncology, Max Super Speciality Hospital, Bathinda, Punjab, India., Safi AJ; Afghanistan Cancer Foundation and Covid-19 Control Command Centre, Kabil, Afghanistan., Agarwal S; Department of Radiotherapy, Jaslok Hospital, Mumbai, Maharashtra, India., Agarwal JP; Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India., Rathnam KK; Department of Medical Oncology, Meenakshi Mission Hospital and Research Centre, Madurai, India., Mohapatra PN; Department of Medical Oncology, Apollo Gleneagles Hospital, Kolkata, West Bengal, India., Kumar RV; Department of Oncology, BGS Gleneagles Global Hospital, Bangalore, India., Rajappa S; Department of Medical Oncology, Basavatarakam Indo American Cancer Hospital and Research Center, Hyderabad, India., Limaye SA; Department of Oncology and Oncology Research, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India., Vora A; Department of Oncology, H.O.P.E. Oncology Cancer Clinic, PSRI Hospital, New Delhi, India., Reddy VAP; Department of Radiation Oncology, Apollo Cancer Institute, Hyderabad, India., Parekh BB; Department of Oncology, Shalby Cancer and Research Institute, Ahmedabad, Gujrat, India., Rath GK; National Cancer Center, Delhi, India.

Publikováno v: South Asian journal of cancer [South Asian J Cancer] 2021 Jan; Vol. 10 (1), pp. 3-8. Date of Electronic Publication: 2021 Aug 20.

A comprehensive review on nanocarriers as a targeted delivery system for the treatment of breast cancer.

Autor: Fatima, Amreen¹, Naseem, Nazish¹, Haider, Md Faheem¹ fhaider89@gmail.com, Rahman, Md Azizur¹, Mall, Jyotiraditya¹, Saifi, Muhammad Sahil¹, Akhtar, Juber¹

Publikováno v: Intelligent Pharmacy. Jun2024, Vol. 2 Issue 3, p415-426. 12p.

A randomized, double-blind, placebo-controlled, phase II study of oral talactoferrin in combination with carboplatin and paclitaxel in previously untreated locally advanced or metastatic non-small cell lung cancer.

Autor: Digumarti R, Wang Y, Raman G, Doval DC, Advani SH, Julka PK, Parikh PM, Patil S, Nag S, Madhavan J, Bapna A, Ranade AA, Varadhachary A, Malik R

Publikováno v: Journal of Thoracic Oncology; 2011 Jun, Vol. 6 Issue 6, p1098-1103, 6p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Importance of dose intensity in treatment of advanced nonsmall cell lung cancer in the elderly

Autor: Prasad, Narayanan, Bakshi, Ashish, Deshmukh, Chetan, Hingmire, Sachin, Ranade, AA, Parikh, Purvish

Publikováno v: South Asian Journal of Cancer; July 2012, Vol. 1 Issue: 1 p09-15, 7p